ArticleThrombosis journal2023

Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.

Xiaozhe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.